Conflict of interest disclosure: striking a balance? Livio GarattiniAnna Padula Editorial 03 January 2019 Pages: 633 - 636
Employment pathways of cancer survivors—analysis from administrative data Joan C. Lo Original Paper 02 January 2019 Pages: 637 - 645
A head-to-head comparison of five-level (EQ-5D-5L-Y) and three-level EQ-5D-Y questionnaires in paediatric patients Carlos King Ho WongPrudence Wing Hang CheungJason Pui Yin Cheung Original Paper 02 January 2019 Pages: 647 - 656
Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data François-Olivier BaudotAnne-Sophie AguadéAnne Fagot-Campagna Original Paper Open access 05 January 2019 Pages: 657 - 668
Hiring subsidies for people with a disability: do they work? Sergi Jiménez-MartínArnau Juanmartí MestresJudit Vall Castelló Original Paper 14 January 2019 Pages: 669 - 689
Catastrophic long-term care expenditure: associated socio-demographic and economic factors Raúl del Pozo-RubioRomán Mínguez-SalidoFrancisco Escribano-Sotos Original Paper 17 January 2019 Pages: 691 - 701
Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study) Maria Rubio-ValeraMaría Teresa Peñarrubia-MaríaAntoni Serrano-Blanco Original Paper 06 February 2019 Pages: 703 - 713
Demand-side determinants of rising hospital admissions in Germany: the role of ageing Jonas KrämerJonas Schreyögg Original Paper Open access 09 February 2019 Pages: 715 - 728
The weekend effect revisited: evidence from the Upper Austrian stroke registry Silvia AngererKlaus ButtingerHarald Stummer Original Paper 12 February 2019 Pages: 729 - 737
Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer Dirk MüllerMarion DannerKerstin Rhiem Original Paper 21 February 2019 Pages: 739 - 750
Estimating the marginal cost of a life year in Sweden’s public healthcare sector Jonathan SiverskogMartin Henriksson Original Paper Open access 22 February 2019 Pages: 751 - 762
A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer Cuc Thi Thu NguyenFabio PetrelliIolanda Grappasonni Original Paper 06 March 2019 Pages: 763 - 777
